Dr. Young is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Mail Stop 54
Los Angeles, CA 90027Phone+1 323-361-5507
Summary
- Guy Young, MD, received his medical degree from the State University of New York at Stony Brook School of Medicine in Stony Brook, New York. He completed a residency in pediatrics at Schneider Children’s Hospital at Long Island Jewish Medical Center, Albert Einstein College of Medicine in New York, and a fellowship in pediatric hematology/oncology at Children’s National Medical Center, George Washington University School of Medicine in Washington, D.C.
Dr. Young is the Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles and a Professor of Pediatrics at the University of Southern California’s Keck School of Medicine.
His current research activities encompass clinical trials in hemophilia, the use of novel anticoagulants in children, and the development of the global hemostasis assays to monitor the effects of medications used to treat bleeding in hemophilia.
Dr. Young has published many journal articles, abstracts, and textbook chapters and has delivered lectures, workshops, and presentations at national and international meetings. He is the past chair of the Scientific and Standardization Committee on Factor VIII, Factor IX, and Rare Bleeding Disorders of the International Society on Thrombosis and Haemostasis and also served on the Scientific Subcommittee on Hemostasis for the American Society of Hematology. He has been awarded the National Hemophilia Foundation Physician of the Year Award in 2013.
Education & Training
- Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1995 - 1998
- Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1992 - 1995
- Stony Brook University Health Sciences Center School of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 1999 - 2025
- MT State Medical License 2023 - 2025
- FL State Medical License 2013 - 2022
- VA State Medical License 1995 - 2000
- MD State Medical License 1998 - 1999
- DC State Medical License 1995 - 1998
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Physician of the Year National Hemophilia Foundation, 2013
Clinical Trials
- A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab Start of enrollment: 2020 Jul 01
- Preventing Inhibitor Recurrence Indefinitely Start of enrollment: 2020 Sep 21
- Emicizumab PUPs and Nuwiq ITI Study Start of enrollment: 2022 Feb 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- CHIEF: A retrospective self-control study of children with severe hemophilia A without inhibitors comparing emicizumab to FVIII prophylaxis.Daniel Mashiach, Patrice Mead, Kendall Carneiro, Jemily Malvar, Susan Knight
Pediatric Blood & Cancer. 2024-12-01 - 2 citationsFitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial.Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann
Blood. 2024-05-30 - Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review.Guy Young, Steven W Pipe, Gili Kenet, Johannes Oldenburg, Mariam Safavi
Research and Practice in Thrombosis and Haemostasis. 2024-05-01
Authored Content
- Bad BloodNovember 2014
Professional Memberships
- Member
- International Society on Thrombosis and HaemostasisMember
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: